Inkocell Therapeutics SA
Inkocell Therapeutics SA, public limited company in Lausanne (VD). Registration active in the commercial register. UID CHE-204.596.277.
Inkocell Therapeutics has developed an NK-tailored CAR receptor engineered specifically for NK cells. It is advancing two lead programs targeting B-cell malignancies and resistance in solid tumors, with future expansion into autoimmune and fibrotic diseases.1
Commercial register
- Legal form
- Public limited company
- Registered office
- c/o Fiduconsult Lausanne SA Place de la Gare 4, 1003 Lausanne
- Share capital
- CHF 100,000
- UID
- CHE-204.596.277
- Registered purpose (original language)
- la Société a pour but en Suisse et à l'étranger, la recherche, le développement, la production, la fabrication et la commercialisation de produits, technologies et services dans les domaines de la biotechnologie, de la pharmacie et des sciences de la vie, en particulier des thérapies cellulaires et des immunothérapies, ainsi que toutes prestations de services et conseils en rapport.
Similar companies
- ImmunSkills SA Monthey
- Onward Therapeutics SA Epalinges Scientific research and development
- Mesoblast International Sàrl Genève
- EVIR Therapeutics SA Nyon Manufacture of basic pharmaceutical products
- Tigen Pharma SA Lausanne Manufacture of basic pharmaceutical products
- BioNOOX SA Lausanne Manufacture of basic pharmaceutical products
A free account opens every company that looks like Inkocell Therapeutics SA, and what they have in common. Create a free account
1 This information was estimated by machine learning and may contain errors.